Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr1034 Inhibitors

Olfr1034 is an olfactory receptor protein. Inhibitors of this protein are chemicals known to affect the olfactory transduction pathway or the functioning of G protein-coupled receptors (GPCRs), which are the broader class of proteins to which Olfr1034 belongs. GPCR inhibitors influence the function of G protein-coupled receptors, a large and diverse group of membrane receptors that play a key role in cellular signaling. The inhibition or modulation of GPCR activity can have a wide range of effects on cellular processes, including those related to sensory perception, like olfaction. GPCRs, upon activation by their specific ligands, initiate a cascade of intracellular events leading to various physiological responses. Inhibitors or modulators of GPCR activity, like beta-blockers (e.g., Propranolol, Nadolol) and alpha-adrenergic antagonists (e.g., Yohimbine, Phentolamine), function by either blocking the receptor, preventing its activation, or by mimicking the action of the endogenous ligand to varying degrees (agonists). This modulation can lead to altered receptor conformations, influencing the receptor's ability to interact with its G protein, and thereby impacting the downstream signaling.

While the direct inhibition of olfactory receptors is not well-explored, the indirect modulation of GPCR activity provides a potential avenue for influencing olfactory receptor function. Since olfactory receptors are a subset of the GPCR family, compounds that affect GPCR signaling could alter the activity of olfactory receptors. This could include changes in receptor sensitivity, signal transduction efficiency, or the receptor's ability to adapt to continuous exposure to a ligand. Although the direct impact of these compounds on olfactory receptors like Olfr1034 is not explicitly established, their role in modulating GPCR-mediated pathways suggests a potential for indirect influence on olfactory signal transduction.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$149.00
$210.00
$714.00
$2550.00
$10750.00
$21410.00
$40290.00
5
(1)

Suramin is a polysulfonated naphthylurea that inhibits various GPCRs, potentially affecting Olfr1034 signaling by altering GPCR-mediated pathways.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol, a non-selective beta-blocker, can influence GPCR activity indirectly, which may have an impact on the signaling of GPCRs like Olfr1034.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$122.00
$235.00
$520.00
$979.00
$1500.00
2
(1)

As a non-selective beta-blocker with alpha-1 blocking activity, Carvedilol can modulate GPCR signaling, potentially influencing Olfr1034 function.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$50.00
$168.00
$520.00
2
(1)

Yohimbine is an alpha-2 adrenergic receptor antagonist, known to modulate GPCR signaling, which may have an indirect effect on Olfr1034 activity.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$27.00
$37.00
5
(0)

Isoproterenol, a non-selective beta-adrenergic agonist, indirectly affects GPCR activity and could potentially influence Olfr1034 function.

Nadolol

42200-33-9sc-253175
1 g
$180.00
(1)

Nadolol is a non-selective beta-adrenergic receptor blocker that can modulate GPCR signaling, possibly impacting Olfr1034-related pathways.

Labetalol

36894-69-6sc-484723
50 mg
$176.00
(0)

Labetalol, with its combined alpha and beta blocking actions, can affect GPCR-mediated signaling, potentially influencing Olfr1034 activity.

Timolol

26839-75-8sc-507468
100 mg
$500.00
(0)

Timolol, a non-selective beta-adrenergic blocker, may indirectly affect the signaling pathways of GPCRs, which could have implications for Olfr1034 signaling.